nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R2—forebrain—attention deficit hyperactivity disorder	0.0362	0.104	CbGeAlD
Isoprenaline—PIK3R3—cardiovascular system—attention deficit hyperactivity disorder	0.0208	0.0597	CbGeAlD
Isoprenaline—PIK3R2—nervous system—attention deficit hyperactivity disorder	0.0196	0.0565	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—attention deficit hyperactivity disorder	0.0189	0.0544	CbGeAlD
Isoprenaline—PIK3R2—cerebellum—attention deficit hyperactivity disorder	0.0185	0.0532	CbGeAlD
Isoprenaline—PIK3R2—brain—attention deficit hyperactivity disorder	0.015	0.0432	CbGeAlD
Isoprenaline—ADRBK1—forebrain—attention deficit hyperactivity disorder	0.0145	0.0417	CbGeAlD
Isoprenaline—MAPK1—forebrain—attention deficit hyperactivity disorder	0.0143	0.0411	CbGeAlD
Isoprenaline—PIK3R1—midbrain—attention deficit hyperactivity disorder	0.0139	0.0398	CbGeAlD
Isoprenaline—PIK3R3—nervous system—attention deficit hyperactivity disorder	0.0133	0.0383	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—attention deficit hyperactivity disorder	0.0128	0.0369	CbGeAlD
Isoprenaline—PIK3R3—cerebellum—attention deficit hyperactivity disorder	0.0125	0.0361	CbGeAlD
Isoprenaline—ADRBK1—cardiovascular system—attention deficit hyperactivity disorder	0.0123	0.0353	CbGeAlD
Isoprenaline—MAPK1—cardiovascular system—attention deficit hyperactivity disorder	0.0121	0.0348	CbGeAlD
Isoprenaline—PIK3R1—cerebellum—attention deficit hyperactivity disorder	0.0107	0.0308	CbGeAlD
Isoprenaline—PIK3R3—brain—attention deficit hyperactivity disorder	0.0102	0.0293	CbGeAlD
Isoprenaline—PIK3R1—brain—attention deficit hyperactivity disorder	0.0087	0.025	CbGeAlD
Isoprenaline—ADRBK1—nervous system—attention deficit hyperactivity disorder	0.00788	0.0227	CbGeAlD
Isoprenaline—MAPK1—nervous system—attention deficit hyperactivity disorder	0.00776	0.0223	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—attention deficit hyperactivity disorder	0.00758	0.0218	CbGeAlD
Isoprenaline—MAPK1—central nervous system—attention deficit hyperactivity disorder	0.00747	0.0215	CbGeAlD
Isoprenaline—ADRBK1—cerebellum—attention deficit hyperactivity disorder	0.00741	0.0213	CbGeAlD
Isoprenaline—MAPK1—cerebellum—attention deficit hyperactivity disorder	0.00731	0.021	CbGeAlD
Isoprenaline—ADRB1—forebrain—attention deficit hyperactivity disorder	0.00607	0.0175	CbGeAlD
Isoprenaline—ADRBK1—brain—attention deficit hyperactivity disorder	0.00602	0.0173	CbGeAlD
Isoprenaline—MAPK1—brain—attention deficit hyperactivity disorder	0.00593	0.0171	CbGeAlD
Isoprenaline—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.00513	0.0148	CbGeAlD
Isoprenaline—Levonordefrin—ADRA2C—attention deficit hyperactivity disorder	0.00334	0.0926	CrCbGaD
Isoprenaline—ADRB1—nervous system—attention deficit hyperactivity disorder	0.0033	0.00948	CbGeAlD
Isoprenaline—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.00317	0.00913	CbGeAlD
Isoprenaline—Methyldopa—COMT—attention deficit hyperactivity disorder	0.00253	0.07	CrCbGaD
Isoprenaline—ADRB1—brain—attention deficit hyperactivity disorder	0.00252	0.00725	CbGeAlD
Isoprenaline—Droxidopa—ADRA2C—attention deficit hyperactivity disorder	0.00235	0.0653	CrCbGaD
Isoprenaline—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00213	0.00611	CbGeAlD
Isoprenaline—L-DOPA—DRD5—attention deficit hyperactivity disorder	0.0021	0.0582	CrCbGaD
Isoprenaline—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00205	0.00589	CbGeAlD
Isoprenaline—Norepinephrine—ADRA2C—attention deficit hyperactivity disorder	0.00198	0.0549	CrCbGaD
Isoprenaline—Phenylephrine—MAOA—attention deficit hyperactivity disorder	0.00195	0.0542	CrCbGaD
Isoprenaline—Dopamine—DRD5—attention deficit hyperactivity disorder	0.00195	0.0542	CrCbGaD
Isoprenaline—Epinephrine—ADRA2C—attention deficit hyperactivity disorder	0.0018	0.0498	CrCbGaD
Isoprenaline—CYP1A1—brain—attention deficit hyperactivity disorder	0.00162	0.00467	CbGeAlD
Isoprenaline—Methyldopa—ADRA2A—attention deficit hyperactivity disorder	0.00161	0.0446	CrCbGaD
Isoprenaline—Levonordefrin—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.0395	CrCbGaD
Isoprenaline—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.00134	0.0373	CrCbGaD
Isoprenaline—Dopamine—COMT—attention deficit hyperactivity disorder	0.00123	0.0342	CrCbGaD
Isoprenaline—L-DOPA—DRD4—attention deficit hyperactivity disorder	0.00108	0.0298	CrCbGaD
Isoprenaline—Droxidopa—ADRA2A—attention deficit hyperactivity disorder	0.001	0.0278	CrCbGaD
Isoprenaline—Dopamine—DRD4—attention deficit hyperactivity disorder	0.001	0.0277	CrCbGaD
Isoprenaline—Dopamine—MAOA—attention deficit hyperactivity disorder	0.00093	0.0258	CrCbGaD
Isoprenaline—L-DOPA—DRD3—attention deficit hyperactivity disorder	0.000927	0.0257	CrCbGaD
Isoprenaline—L-DOPA—DRD1—attention deficit hyperactivity disorder	0.00091	0.0252	CrCbGaD
Isoprenaline—Dopamine—DRD3—attention deficit hyperactivity disorder	0.000862	0.0239	CrCbGaD
Isoprenaline—Dopamine—DRD1—attention deficit hyperactivity disorder	0.000846	0.0234	CrCbGaD
Isoprenaline—Norepinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000846	0.0234	CrCbGaD
Isoprenaline—Dopamine—SLC6A3—attention deficit hyperactivity disorder	0.000802	0.0222	CrCbGaD
Isoprenaline—Epinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000767	0.0213	CrCbGaD
Isoprenaline—L-DOPA—DRD2—attention deficit hyperactivity disorder	0.000642	0.0178	CrCbGaD
Isoprenaline—Norepinephrine—DRD2—attention deficit hyperactivity disorder	0.000642	0.0178	CrCbGaD
Isoprenaline—Dopamine—SLC6A4—attention deficit hyperactivity disorder	0.0006	0.0166	CrCbGaD
Isoprenaline—Dopamine—DRD2—attention deficit hyperactivity disorder	0.000596	0.0165	CrCbGaD
Isoprenaline—PIK3R2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000313	0.000508	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000312	0.000505	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00031	0.000504	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000309	0.000501	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000309	0.000501	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000309	0.000501	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000308	0.0005	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000307	0.000499	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000307	0.000498	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000306	0.000497	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000306	0.000496	CbGpPWpGaD
Isoprenaline—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000305	0.000495	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000305	0.000494	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000302	0.00049	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000301	0.000489	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000301	0.000489	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000301	0.000489	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000301	0.000488	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.0003	0.000487	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0003	0.000487	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000299	0.000485	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000299	0.000485	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000299	0.000485	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000298	0.000484	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000298	0.000484	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000297	0.000482	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000295	0.000479	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000295	0.000479	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000295	0.000478	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000294	0.000478	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000294	0.000477	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000294	0.000477	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000291	0.000472	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00029	0.000471	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000289	0.000469	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000288	0.000468	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000287	0.000466	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000286	0.000465	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000285	0.000463	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000284	0.000461	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000282	0.000458	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00028	0.000455	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000278	0.000451	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000278	0.000451	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000277	0.000449	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000273	0.000444	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000273	0.000443	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000271	0.00044	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00027	0.000439	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00027	0.000438	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000267	0.000433	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000265	0.000431	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000263	0.000428	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000263	0.000426	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000261	0.000424	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00026	0.000421	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000258	0.000418	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000255	0.000414	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000254	0.000413	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000254	0.000412	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000254	0.000412	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000254	0.000412	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000252	0.000409	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000251	0.000408	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00025	0.000406	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00025	0.000406	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00025	0.000405	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000247	0.000401	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000245	0.000398	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000243	0.000395	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000242	0.000393	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000241	0.000391	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00024	0.00039	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000239	0.000388	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000238	0.000387	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000238	0.000386	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000236	0.000384	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000236	0.000383	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000232	0.000377	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00023	0.000373	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000229	0.000372	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000227	0.000368	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000225	0.000366	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000225	0.000365	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000222	0.00036	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00022	0.000358	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000217	0.000353	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000214	0.000347	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00021	0.000341	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000209	0.00034	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000209	0.000339	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000209	0.000339	CbGpPWpGaD
Isoprenaline—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000208	0.000337	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000207	0.000336	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000206	0.000335	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000205	0.000332	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000205	0.000332	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000204	0.000331	CbGpPWpGaD
Isoprenaline—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000203	0.00033	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000203	0.000329	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000203	0.000329	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000203	0.000329	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000201	0.000326	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000201	0.000326	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.0002	0.000325	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0002	0.000324	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000199	0.000323	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000199	0.000323	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000197	0.00032	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000197	0.000319	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000196	0.000319	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000195	0.000317	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000194	0.000316	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000194	0.000315	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000194	0.000315	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000193	0.000313	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000193	0.000313	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00019	0.000308	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000189	0.000307	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000189	0.000307	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000188	0.000306	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000186	0.000302	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000186	0.000301	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000183	0.000298	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000183	0.000298	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000183	0.000297	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000183	0.000296	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000182	0.000296	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000181	0.000293	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000181	0.000293	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000179	0.000291	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000179	0.00029	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000178	0.000289	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000178	0.000289	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000178	0.000289	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000177	0.000288	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000176	0.000286	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000175	0.000284	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000174	0.000283	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000174	0.000283	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000174	0.000283	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000174	0.000282	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000172	0.000279	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000172	0.000279	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000171	0.000278	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000171	0.000277	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000171	0.000277	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000171	0.000277	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00017	0.000275	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000168	0.000273	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000167	0.000272	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000166	0.00027	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000166	0.000269	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000165	0.000267	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000164	0.000267	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000163	0.000264	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000163	0.000264	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000161	0.000262	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000161	0.000261	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000161	0.000261	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00016	0.00026	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00016	0.00026	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000159	0.000259	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000158	0.000257	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000158	0.000256	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000158	0.000256	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000157	0.000255	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000156	0.000254	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000156	0.000253	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000155	0.000251	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000154	0.000249	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000153	0.000248	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000153	0.000248	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000149	0.000241	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000148	0.00024	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000146	0.000238	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000146	0.000236	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000145	0.000235	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000143	0.000231	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000142	0.00023	CbGpPWpGaD
Isoprenaline—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.00014	0.000227	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000139	0.000225	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—EP300—attention deficit hyperactivity disorder	0.000132	0.000214	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000128	0.000208	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000126	0.000205	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000124	0.000201	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—EP300—attention deficit hyperactivity disorder	0.000122	0.000198	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000121	0.000196	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00012	0.000194	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000118	0.000192	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000117	0.000189	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000115	0.000187	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000113	0.000183	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000112	0.000182	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000112	0.000181	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000111	0.000179	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00011	0.000178	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.000178	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000108	0.000176	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000106	0.000172	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—EP300—attention deficit hyperactivity disorder	0.000105	0.000171	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000104	0.000169	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000104	0.000169	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—EP300—attention deficit hyperactivity disorder	0.000104	0.000168	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000103	0.000168	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000102	0.000166	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000102	0.000166	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000102	0.000165	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000101	0.000164	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.98e-05	0.000162	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—EP300—attention deficit hyperactivity disorder	9.95e-05	0.000161	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.83e-05	0.000159	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—EP300—attention deficit hyperactivity disorder	9.72e-05	0.000158	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.61e-05	0.000156	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—EP300—attention deficit hyperactivity disorder	9.57e-05	0.000155	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	9.57e-05	0.000155	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.57e-05	0.000155	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.52e-05	0.000154	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.41e-05	0.000153	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.35e-05	0.000152	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.31e-05	0.000151	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.24e-05	0.00015	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.15e-05	0.000148	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.04e-05	0.000147	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.75e-05	0.000142	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.61e-05	0.00014	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.53e-05	0.000138	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—EP300—attention deficit hyperactivity disorder	8.53e-05	0.000138	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.42e-05	0.000137	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—EP300—attention deficit hyperactivity disorder	8.14e-05	0.000132	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—EP300—attention deficit hyperactivity disorder	7.87e-05	0.000128	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.65e-05	0.000124	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.28e-05	0.000118	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.07e-05	0.000115	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.8e-05	0.00011	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.7e-05	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—EP300—attention deficit hyperactivity disorder	6.59e-05	0.000107	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.03e-05	9.78e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.9e-05	9.57e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	5.8e-05	9.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EP300—attention deficit hyperactivity disorder	5.8e-05	9.4e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.76e-05	9.34e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.58e-05	9.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.51e-05	8.94e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.38e-05	8.73e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EP300—attention deficit hyperactivity disorder	5.35e-05	8.68e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.75e-05	6.08e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.19e-05	5.18e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.12e-05	5.07e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	2.49e-05	4.03e-05	CbGpPWpGaD
